MP66-02 DOWN-REGULATION OF CDKN3 INHIBITED PROSTATE CANCER PROLIFERATION IN VITRO AND IN VIVO VIA REGULATING CELL CYCLE AND DNA REPLICATION SIGNALING

yiping zhu,dingwei ye,bo dai

DOI: https://doi.org/10.1016/j.juro.2016.02.1276

2016-01-01

Abstract:You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology II1 Apr 2016MP66-02 DOWN-REGULATION OF CDKN3 INHIBITED PROSTATE CANCER PROLIFERATION IN VITRO AND IN VIVO VIA REGULATING CELL CYCLE AND DNA REPLICATION SIGNALING yiping zhu, dingwei ye, and bo dai yiping zhuyiping zhu More articles by this author , dingwei yedingwei ye More articles by this author , and bo daibo dai More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2016.02.1276AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Cyclin-dependent kinase inhibitor 3 (CDKN3) is aberrantly expressed in several human cancers and plays an important role in regulating cell division. However, the functional role of CDKN3 in prostate cancer (PCa) remains to be elucidated. In this study, we explored its functional role and the molecular mechanisms in human PCa cell lines. METHODS We first assayed the expression of CDKN3 in PCa tissue samples and PCa cell lines by real-time PCR and western blotting. We then defined the biological functions of CDKN3 by CCK-8 assay, flow cytometry and transwell assay. We used Gene set enrichment analysis (GSEA) of KEGG dataset to probe the CDKN3-associated pathways and confirmed the findings from GSEA by Western blotting. Nude mouse xenograft experiment was performed to assay the effect of CDKN3 down-regulation on tumor growth. RESULTS CDKN3 expression was markedly increased in prostate cancer tissues and prostate cancer cell lines LNcap and PC3(Figure 1). Moreover, down-regulation of CDKN3 inhibited cell proliferation, induced a G1 phase arrest in cell cycle, inhibited cell invasion and promoted cell apoptosis in LNcap and PC3 cells. GSEA showed that cell cycle and DNA replication signaling were correlatively with CDKN3 expression. Western blot results showed that the expression levels of cell cycle related proteins PCNA and CDK1 were down-regulated and DNA replication related proteins MCM2 and MCM3 were also reduced (Figure 2). Finally, in vivo data showed that knockdown of CDKN3 expression dramatically inhibited the prostate tumor growth in nude mouse (Figure 3). CONCLUSIONS Our data suggest an important role of CDKN3 in the molecular etiology of prostate cancer and implicate the potential application of CDKN3 in prostate cancer therapy. © 2016FiguresReferencesRelatedDetails Volume 195Issue 4SApril 2016Page: e873 Advertisement Copyright & Permissions© 2016MetricsAuthor Information yiping zhu More articles by this author dingwei ye More articles by this author bo dai More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...